Efficacy and Safety of Atezolizumab Plus Bevacizumab in Patients With Advanced NSCLC Who Received Pretreatment With EGFR‐TKIs (ML41256): A Multicenter, Prospective, Single‐Arm, Phase 2 Trial. Here, EGFR is linked to non-small cell lung carcinoma.